{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:02:01Z","timestamp":1780963321990,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04473-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:52:50Z","timestamp":1777002770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Policy window period: analysis of HPV vaccination status among age-eligible girls in China (before national immunisation programme implementation)"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin-xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"3","key":"4473_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4473_CR2","first-page":"317","volume":"16","author":"XX Sun","year":"2024","unstructured":"Sun XX, Wang YP, Si M, l, et al. Trends of cervical cancer incidence and death and its age-Period cohort modeling in China, 1990\u20132019. Chin J Cancer Prev Control. 2024;16(3):317\u201320.","journal-title":"Chin J Cancer Prev Control"},{"issue":"5","key":"4473_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, et al. EPidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364.","journal-title":"Hepatology"},{"issue":"02","key":"4473_CR4","first-page":"176","volume":"26","author":"MX Li","year":"2025","unstructured":"Li MX, Zhao FH, Yin RT, et al. Guidelines for the Clinical APPlication of ProPhylactic Human PaPillomavirus Vaccines in China (2025 Edition). Chin J Clin Obstet Gynecol. 2025;26(02):176\u201387.","journal-title":"Chin J Clin Obstet Gynecol"},{"issue":"5","key":"4473_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2012.11.083","volume":"31","author":"LAV Marow","year":"2013","unstructured":"Marow LAV, Zimet GD, Meeaffery KJ, et al. Knowledge of human PaPil-lomavirus (HPV) and HPV vaceination: an interational comParison. Vaceine. 2013;31(5):763\u20139.","journal-title":"Vaceine"},{"key":"4473_CR6","unstructured":"WHO. Human PaPillomavirus vaccines: WHO Position PaPer, December 2022 [EB\/0L]. (2022-12-16)[2024-12-05]. https:\/\/www.who.int\/Publications\/i\/item\/who-wer9750-645-672."},{"key":"4473_CR7","doi-asserted-by":"publisher","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","volume":"144","author":"L Brun","year":"2021","unstructured":"Bruni L, Saura-L\u00e1zaro A, Montoliu A, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization cover-age 2010\u20132019. Prev Med. 2021;144:106399.","journal-title":"Prev Med"},{"key":"4473_CR8","unstructured":"World Health Organization. HPV vaccine included in nationa! immunization[EB\/OL]. [2024-6-28]. https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/4694."},{"key":"4473_CR9","unstructured":"Wang L, Zhao G. Comprehensive Prevention and Control Guidelines for Cervical Cancer (2nd ed). Beijing: People\u2019s Medical Publishing House; 2023."},{"issue":"5","key":"4473_CR10","first-page":"60","volume":"106","author":"I Moodley","year":"2016","unstructured":"Moodley I, Tathiah N, Sarorius B. The costs of delivering humanPaPillomavirus vaccinalion to Grade 4 learners in KwaZulu- Natal, South Africa. South Afr Med J. 2016;106(5):60.","journal-title":"South Afr Med J"},{"issue":"5","key":"4473_CR11","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/cam4.2048","volume":"8","author":"E Altobelli","year":"2019","unstructured":"Altobelli E, RaPacchietta L, Profeta VF, et al. HPV-vaccination and cancer cervical screening in 53 WHO EuroPean Countries: An uPdate on Prevention Programs according to income level. Cancer Med. 2019;8(5):2524\u201334.","journal-title":"Cancer Med"},{"issue":"1","key":"4473_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1186\/s12913-023-10283-3","volume":"23","author":"JA Kiendr\u00e9b\u00e9ogo","year":"2023","unstructured":"Kiendr\u00e9b\u00e9ogo JA, Sidibe ARO, Compaor\u00e9 GB, et al. Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study. BMC Health Serv Res. 2023;23(1):1338.","journal-title":"BMC Health Serv Res"},{"issue":"39","key":"4473_CR13","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1016\/j.vaccine.2015.07.088","volume":"33","author":"E Lefevere","year":"2015","unstructured":"Lefevere E, Theeten H, Hens N, et al. From non-school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage, and socioeconomic inequalities. VACCINE. 2015;33(39):5188\u201395.","journal-title":"VACCINE"},{"issue":"3","key":"4473_CR14","doi-asserted-by":"publisher","first-page":"e250747","DOI":"10.1001\/jamanetworkopen.2025.0747","volume":"8","author":"E Oka","year":"2025","unstructured":"Oka E, Okada M, Ikuno Y, et al. Area Socioeconomic Status, Vaccination Access, and Female Human Papillomavirus Vaccination. JAMA Netw Open. 2025;8(3):e250747.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4473_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12879-024-10263-w","volume":"25","author":"BMO Luvisaro","year":"2025","unstructured":"Luvisaro BMO, da Silva TPR, Gusm\u00e3o JD, et al. Association between contextual factors and vaccine coverage against human papillomavirus in adolescents in the state of Minas Gerais, Brazil: global spatial regressions. BMC Infect Dis. 2025;25(1):34.","journal-title":"BMC Infect Dis"},{"key":"4473_CR16","doi-asserted-by":"crossref","unstructured":"Soares GH, Sethi S, Hedges. Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis. Vaccine. 2022;40(32):4644\u201353.","DOI":"10.1016\/j.vaccine.2022.06.030"},{"key":"4473_CR17","doi-asserted-by":"publisher","unstructured":"Costantino C, Tabacchi G, Sannasardo C, et al. Systematic review and meta-analysis of determinants associated with HPV vaccination uptake in Europe. Eur J Public Health. 2020;30(5). https:\/\/doi.org\/10.1093\/eurpub\/ckaa166.1438.","DOI":"10.1093\/eurpub\/ckaa166.1438"},{"issue":"1","key":"4473_CR18","doi-asserted-by":"publisher","first-page":"e000726","DOI":"10.1136\/bmjmed-2023-000726","volume":"3","author":"RM Casey","year":"2024","unstructured":"Casey RM, Akaba H, Hyde TB, et al. COVID-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. BMJ Med. 2024;3(1):e000726.","journal-title":"BMJ Med"},{"issue":"23","key":"4473_CR19","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1016\/j.vaccine.2023.04.060","volume":"41","author":"SS Voss","year":"2023","unstructured":"Voss SS, N\u00f8rgaard SK, Valentiner-Branth P. Identification of subgroups in the Danish population for targeted human papillomavirus vaccination efforts. VACCINE. 2023;41(23):3525\u201333.","journal-title":"VACCINE"},{"issue":"5","key":"4473_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.20965\/jdr.2023.p0531","volume":"18","author":"D Wang","year":"2023","unstructured":"Wang D, Liu P, Xu Z, et al. Spatial Layout and Accessibility Evaluation of COVID-19 Vaccination Sites Based on Three Optimization Models: A Case Study of Tianhe District. Guangzhou JDR. 2023;18(5):531\u201342.","journal-title":"Guangzhou JDR"},{"key":"4473_CR21","doi-asserted-by":"publisher","first-page":"127579","DOI":"10.1016\/j.vaccine.2025.127579","volume":"62","author":"J Li","year":"2025","unstructured":"Li J, Zhao D, Zi. T.Evolving trends in HPV vaccination coverage among women aged 9\u201345 in Chengdu, China: insights from 2017 to 2023. Vaccine. 2025;62:127579.","journal-title":"Vaccine"},{"issue":"1","key":"4473_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12889-022-14947-3","volume":"3","author":"Y Li","year":"2022","unstructured":"Li Y, Qin C, Qiu S, Wu. D.The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15-18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China. BMC Public Health. 2022;3(1):48.","journal-title":"BMC Public Health"},{"key":"4473_CR23","unstructured":"National Bureau of Disease Control and Prevention, National Health Commission, Ministry of Education, et al. (2025). Notice on incorporating human papillomavirus vaccine into national immunization program (Guoji Kongyi Weimian Fa [2025] No.16). Chinese Government Official Website. Retrieved March 19, 2026, from URL. https:\/\/www.gov.cn\/zhengce\/zhengceku\/202510\/content_7046467.htm"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04473-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:38:31Z","timestamp":1780961911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04473-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The Human Subjects Ethics Committee of the study hospital approved the study. Parents were informed of the study\u2019s purpose and content. Written informed consent was obtained from parents and caregivers. To ensure patient privacy, all participants\u2019 personal or sensitive information was assigned an alphabetical or numerical code. All the authors agree with the content of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}